← FDA Drug Approvals (Drugs@FDA)
CLOBAZAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-09-06
Drug application
- FDA Application #
ANDA216008- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOBAZAM
- Generic name
- Clobazam
- Active ingredients
- CLOBAZAM
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACCORD HLTHCARE
- First approval
- 2022-09-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown